Simponi - direct healthcare professional communication (DHPC)

Golimumab

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Simponi (golimumab) 50 mg and 100 mg: important changes to the injection instructions for the SmartJect Pre-filled Pen

Key facts

• Medicine name:
  Simponi
• Active substance:
  Golimumab
• Therapeutic area (MeSH):
  • Arthritis, Psoriatic
  • Spondylitis, Ankylosing
  • Colitis, Ulcerative
  • Arthritis, Rheumatoid
• Regulatory outcome:
  Variation
• DHPC type:
  Quality defect
• Human ATC codes:
  L04AB06
• Dissemination date:
  09/08/2023